Sign in
4

Changes in Ownership

INTERPACE BIOSCIENCES, INC. Filed Acc 0001192482-18-000491

Options or other derivatives

  • Chief Commerical Officer acquired 67,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Richard Gregory · Chief Commerical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-05 Grant or award : show line 1 in the form Stock Option (right to buy) +67,000 67,000 D
Loading xslF345X03/edgar.xml…